20.34
+0.04(+0.20%)
Currency In CNY
Sector
Healthcare
Industry
Biotechnology
Employees
5298
First IPO Date
June 16, 1998
| Name | Title | Pay | Year Born |
| Ms. Xiang Ci | General Counsel & Chief Compliance Officer | 0 | 1981 |
| Ms. Yana Liu | Deputy GM & Director | 0 | 1976 |
| Mr. Hongqing Wang | Chief Financial Officer | 0 | 1982 |
| Mr. Hui Chuan Yang | Chairman of the Board | 0 | 1969 |
| Mr. Yanlin He | Deputy GM & Director | 0 | 1968 |
Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and consulting of blood products in China. Its products include blood intravenous injection immunoglobulin; blood human albumin; blood system intravenous injection; hepatitis B, freeze-dried hepatitis B, and tetanus human immunoglobulin; human immunoglobulin; and other blood products. The company was incorporated in 1998 and is headquartered in Beijing, China. Beijing Tiantan Biological Products Co., Ltd. operates as a subsidiary of China National Biotec Group Company Limited.